Abbott Laboratories closes $6.2 billion buyout of Solvay’s pharmaceutical business (Minneapolis-St. Paul Star Tribune)
NEW YORK – Abbott Laboratories said Tuesday it completed the $6.2 billion buyout of Solvay’s pharmaceutical business. On Thursday, the companies received European antitrust approval for the deal, clearing the way for the deal to close.
Here is the original post:
Abbott Laboratories closes $6.2 billion buyout of Solvay’s pharmaceutical business (Minneapolis-St. Paul Star Tribune)
